Share

December 2016; 6 (6) Guideline PerspectiveOpen Access

Rehabilitation in multiple sclerosis

Commentary on the recent AAN systematic review

Matthew H. Sutliff, Susan E. Bennett, Patricia Bobryk, June Halper, Lori A. Saslow, Lisa T. Skutnik, Christine Smith, Kathleen Zackowski, David E. Jones
First published October 27, 2016, DOI: https://doi.org/10.1212/CPJ.0000000000000318
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
3275

Share

Article Information

vol. 6 no. 6 475-479
DOI: 
https://doi.org/10.1212/CPJ.0000000000000318
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received April 18, 2016
  • Accepted October 6, 2016
  • First Published October 27, 2016.

Article Versions

Copyright & Usage: 
© 2016 American Academy of Neurology This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License 4.0 (CC BY-NC-ND), which permits downloading and sharing the work provided it is properly cited. The work cannot be changed in any way or used commercially.

Author Disclosures

    1. Matthew H. Sutliff, PT, MSCS,
    2. Susan E. Bennett, PT, DPT, EdD, NCS, MSCS,
    3. Patricia Bobryk, MHS, PT, MSCS, ATP,
    4. June Halper, MSN, APN-C, MSCN,
    5. Lori A. Saslow, MS,
    6. Lisa T. Skutnik, PT, MA, MA,
    7. Christine Smith, OTR/L, MSCS,
    8. Kathleen Zackowski, PhD, OTR, MSCS, CRND and
    9. David E. Jones, MD
  1. Matthew H. Sutliff, PT, MSCS,
    2. Scientific Advisory Boards:

    1. Acorda Therapeutics advisory board

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Acorda Therapeutics speakers bureau

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Acorda Therapeutics speakers bureau

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. Geauga Rehabilitation Engineering - royalties for sales of the Hip Flexion Assist Device (HFAD)

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Susan E. Bennett, PT, DPT, EdD, NCS, MSCS,
    3. Scientific Advisory Boards:

    1. Acorda Therapeutics EMD Serono on a new APP

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Acorda Therapeutics

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. Acorda Therapeutics

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Patricia Bobryk, MHS, PT, MSCS, ATP,
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Non-Profit: Travel/moderator honoraria CMSC Annual Meeting Non-Profit: Travel/speaker honoraria MS Foundation Non-profit: Speaker, Can Do Multiple Sclerosis

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. June Halper, MSN, APN-C, MSCN,
    5. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. International Journal of MS Care, 1999-present. CEO of CMSC

    Patents:

    1. NONE

    Publishing Royalties:

    1. Nursing Care in Multiple Sclerosis: A Core Curriculum. 2011. Springer Medical Publishing. NYC.

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  5. Lori A. Saslow, MS,
    6. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Consortium of Multiple Sclerosis Centers

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  6. Lisa T. Skutnik, PT, MA, MA,
    7. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Biogen - travel and hotel funding to attend meeting

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Biogen

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  7. Christine Smith, OTR/L, MSCS,
    8. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other activities:

    1. Author on a rehabilitation primer produced by the France Foundation

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. Ownership interest (stock, stock options, other): Teva

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  8. Kathleen Zackowski, PhD, OTR, MSCS, CRND and
    9. Scientific Advisory Boards:

    1. (1) Consortium of MS Centers.

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. (1) ReWalk Robotics

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. (1) Acorda Therapeutics, (3) Minoryx Therapeutics

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. (1) National MS Society

    Stock/Stock Options/Board of Directors Compensation:

    1. (1) Consortium of MS Centers, expense compensation. (2) National MS Society

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  9. David E. Jones, MD
    10. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for travel or speaker honoraria:

    1. Honorarium, MS Foundation Honorarium, Multiple Sclerosis Association of America Honorarium, Consortium of MS Centers Travel, American Academy of Neurology Travel, Consortium of MS Centers Travel, Multiple Sclerosis Association of America Travel, Can Do MS

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. (1) Biogen -- 2 consultant meetings (2) Novartis -- 1 consultant meeting (3) Pharmacy Quality Alliance

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. Biogen National MS Society

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. University of Virginia

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Mellen Center for MS Treatment and Research (MHS), Neurological Institute, Cleveland Clinic, OH; University of Buffalo (SEB), SUNY, NY; Comprehensive Care Center of Central Florida (PB), Orlando; Consortium of Multiple Sclerosis Centers (JH, LTS), International Organization of MS Nurses, Hackensack, NJ; LS Science & Medical Communications, LLC (LAS), Great Neck, NY; Center for Physical Rehabilitation (CS), Holy Name Medical Center, Teaneck, NJ; Kennedy Krieger Institute (KZ), Johns Hopkins University School of Medicine, Baltimore, MD; and University of Virginia Health System (DEJ), Charlottesville.
  1. Correspondence to:
    Dj9d{at}virginia.edu
View Full Text

Article usage

Article usage: October 2016 to August 2023

AbstractFullPdfSource
Oct 20164008Highwire
Nov 20166780109Highwire
Dec 20161714382277Highwire
Jan 2017876154159Highwire
Jan 2017011335pmc
Feb 20172044553Highwire
Feb 201707137pmc
Mar 20171742754Highwire
Mar 201706023pmc
Apr 20171243862Highwire
Apr 2017163536pmc
May 20171073839Highwire
May 2017132735pmc
Jun 2017533436Highwire
Jun 201792226pmc
Jul 2017622846Highwire
Jul 201731618pmc
Aug 2017461453Highwire
Aug 201721415pmc
Sep 2017381748Highwire
Sep 201762537pmc
Oct 2017472368Highwire
Oct 2017104651pmc
Nov 2017512475Highwire
Nov 201753245pmc
Dec 2017133669Highwire
Jan 201862872Highwire
Feb 2018174754Highwire
Mar 201869956Highwire
Apr 201884457Highwire
Apr 2018218194pmc
May 2018916059Highwire
Jun 2018310941Highwire
Jun 20182893112pmc
Jul 2018159931Highwire
Aug 201856628Highwire
Aug 2018209396pmc
Sep 201835925Highwire
Oct 201807532Highwire
Nov 201859113Highwire
Dec 201856722Highwire
Jan 201966822Highwire
Feb 2019107236Highwire
Mar 201957932Highwire
Apr 201986024Highwire
May 2019118327Highwire
Jun 201988030Highwire
Jul 2019810022Highwire
Aug 201964230Highwire
Sep 201964729Highwire
Oct 2019166726Highwire
Nov 2019105835Highwire
Dec 2019165025Highwire
Jan 2020165115Highwire
Feb 2020215432Highwire
Mar 2020198522Highwire
Apr 202077116Highwire
May 2020145621Highwire
Jun 20207338Highwire
Jul 202073922Highwire
Aug 202063112Highwire
Sep 2020137214Highwire
Oct 2020254716Highwire
Nov 202034222Highwire
Dec 202074413Highwire
Jan 202112710Highwire
Feb 202174911Highwire
Mar 20216369Highwire
Apr 20216348Highwire
May 202153513Highwire
Jun 20218363Highwire
Jul 202182114Highwire
Aug 2021164915Highwire
Sep 202144311Highwire
Oct 202185037Highwire
Nov 202183427Highwire
Dec 2021153424Highwire
Jan 202212396Highwire
Feb 2022163922Highwire
Mar 202252412Highwire
Apr 202273711Highwire
May 202244416Highwire
Jun 202211258Highwire
Jul 20226318Highwire
Aug 202242510Highwire
Sep 202285718Highwire
Oct 202283111Highwire
Nov 202276624Highwire
Dec 20225218Highwire
Jan 202343411Highwire
Feb 202392511Highwire
Mar 20232156Highwire
Apr 202351313Highwire
May 202383414Highwire
Jun 20234288Highwire
Jul 202351911Highwire
Aug 2023378Highwire

The Nerve!: Rapid online correspondence

Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Topics Discussed

Alert Me

Recommended articles